100 related articles for article (PubMed ID: 7524530)
1. Could the cytokeratin molecule be modulated during tumor transformation in hepatocellular carcinoma?
Su B; Pei RJ; Yeh KT; Hsu YH; Lai YS
Pathobiology; 1994; 62(3):155-9. PubMed ID: 7524530
[TBL] [Abstract][Full Text] [Related]
2. HCC CKs are altered histones during tumor transformation in hepatoma.
Liu YH; Pei RJ; Cheng CC; Ho HC; Ho CC; Yeh KT; Lee KY; Lai YS
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):27-38. PubMed ID: 15080494
[TBL] [Abstract][Full Text] [Related]
3. The stability of cytokeratin 18 in human liver cells during colchicine-induced microtubule disruption.
Liu Y; Su B; Pei R; Yeh C; Yeh K; Ying Lee K; Hsu Y; Ho C; Lai Y
Food Chem Toxicol; 2001 Jan; 39(1):85-9. PubMed ID: 11259854
[TBL] [Abstract][Full Text] [Related]
4. The expression of cytokeratin 18 in transitional cell carcinoma comparing with hepatoma.
Yeh CC; Pei RJ; Liu YH; Su B; Lee KY; Yeh KT; Hsu YH; Ho CC; Ho HC; Lai YS
Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):3-10. PubMed ID: 10850364
[TBL] [Abstract][Full Text] [Related]
5. The alteration of cytokeratin 18 molecule and its mRNA expression during tumor transformation in hepatoma.
Liu YH; Pei RJ; Yeh CC; Lee KY; Yeh KT; Hsu YH; Ho CC; Lai YS
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):243-53. PubMed ID: 9261884
[TBL] [Abstract][Full Text] [Related]
6. Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver.
Van Eyken P; Sciot R; Brock P; Casteels-Van Daele M; Ramaekers FC; Desmet VJ
Histopathology; 1990 Aug; 17(2):101-7. PubMed ID: 1699871
[TBL] [Abstract][Full Text] [Related]
7. Do the CK18 related proteins change in general in epithelial cancers?
Pei RJ; Liu YH; Su B; Yeh CC; Lee KY; Yeh KT; Hsu YH; Ho CC; Lai YS
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):253-60. PubMed ID: 11913716
[TBL] [Abstract][Full Text] [Related]
8. Possible relation between histone 3 and cytokeratin 18 in human hepatocellular carcinoma.
Ho CC; Cheng CC; Liu YH; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
In Vivo; 2008; 22(4):457-62. PubMed ID: 18712172
[TBL] [Abstract][Full Text] [Related]
9. A cytokeratin-immunohistochemical study of hepatoblastoma.
Van Eyken P; Sciot R; Callea F; Ramaekers F; Schaart G; Desmet VJ
Hum Pathol; 1990 Mar; 21(3):302-8. PubMed ID: 1690171
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study.
Van Eyken P; Sciot R; Paterson A; Callea F; Kew MC; Desmet VJ
Hum Pathol; 1988 May; 19(5):562-8. PubMed ID: 2453442
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemistry of cytokeratins in primary human liver tumors.
Van Eyken P; Sciot R; Desmet VJ
APMIS Suppl; 1991; 23():77-85. PubMed ID: 1715730
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
[TBL] [Abstract][Full Text] [Related]
13. Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.
Uenishi T; Kubo S; Hirohashi K; Yamamoto T; Ogawa M; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1101-4. PubMed ID: 12845990
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 18-associated Histone 3 Modulation in Hepatocellular Carcinoma: A Mini Review.
Lai YC; Cheng CC; Lai YS; Liu YH
Cancer Genomics Proteomics; 2017; 14(4):219-223. PubMed ID: 28647696
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein.
Kang SM; Shin MJ; Kim JH; Oh JW
Proteomics; 2005 May; 5(8):2227-37. PubMed ID: 15846844
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas.
Lai YS; Thung SN; Gerber MA; Chen ML; Schaffner F
Arch Pathol Lab Med; 1989 Feb; 113(2):134-8. PubMed ID: 2464975
[TBL] [Abstract][Full Text] [Related]
17. Hypoacetylation in association with histone 3 modulation in human hepatocellular carcinoma.
Cheng CC; Liu YH; Lai YC; Hsu YH; Chao WT; Lai YS
In Vivo; 2015; 29(2):237-42. PubMed ID: 25792651
[TBL] [Abstract][Full Text] [Related]
18. Absence of cytokeratin in human hepatoma cell lines.
Lo SJ; Yang CW; Hu CP; Chang CM
Cell Biol Int Rep; 1987 Jun; 11(6):477-86. PubMed ID: 2441881
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma.
Attallah AM; El-Far M; Abdel Malak CA; Zahran F; Farid K; Omran MM; Zagloul H; El-Deen MS
Clin Chim Acta; 2011 Nov; 412(23-24):2310-5. PubMed ID: 21924253
[TBL] [Abstract][Full Text] [Related]
20. Cross-linked cytokeratin polypeptides in liver and hepatoma cells: possible association with the process of cell degeneration and death.
Fukuda K; Kojiro M; Chiu JF
Hepatology; 1993 Jan; 17(1):118-24. PubMed ID: 7678572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
